• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Captopril in hypertensive black men in southern Africa.

作者信息

Cowie R L, Dansey R D

机构信息

Department of Medicine, Ernest Oppenheimer Hospital, Welkom, OFS.

出版信息

S Afr Med J. 1990 Oct 20;78(8):455-6.

PMID:2218779
Abstract

A group of 55 black men with mild or moderate hypertension who were being treated with methyldopa, prazosin, and a thiazide diuretic in combination with sotalol, were studied before and after changing their treatment to captopril and a thiazide diuretic. The level of blood pressure control was similar in the 11 men with mild hypertension but the 44 men with moderate hypertension were less well controlled with captopril and a thiazide diuretic. In the men with moderate hypertension the mean increase in the systolic blood pressure after the change in treatment was 4.7 mmHg (not significant) and in the diastolic pressure 6.2 mmHg (P less than 0.02). The mean blood pressure was higher during treatment with captopril in 37 men and lower in 18 men (P = 0.01). Thirty-seven men found both regimens acceptable and 33 of these men preferred the captopril regimen; however, 15 men said they did not like the captopril regimen while only 4 men did not like the methyldopa/prazosin regimen (P less than 0.01). Side-effects from the captopril regimen were reported by 18 of the men and from the methyldopa/prazosin regimen by 6 men (P less than 0.02). It was concluded that the captopril/thiazide regimen was less effective than the methyldopa/prazosin/sotalol/thiazide regimen for the control of moderate hypertension in this population of black men. Although the men who liked both regimens preferred the captopril regimen, that regimen was associated with significantly more side-effects and was disliked by more of the men than was the methyldopa/prazosin regimen.

摘要

相似文献

1
Captopril in hypertensive black men in southern Africa.
S Afr Med J. 1990 Oct 20;78(8):455-6.
2
Comparative evaluation of captopril and methyldopa monotherapy for hypertension: double-blind study in Indians.
Clin Ther. 1986;8(5):482-9.
3
The effects of antihypertensive therapy on the quality of life.抗高血压治疗对生活质量的影响。
N Engl J Med. 1986 Jun 26;314(26):1657-64. doi: 10.1056/NEJM198606263142602.
4
Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.与接受伊拉地平或甲基多巴单药治疗或联合卡托普利治疗的高血压男性相比,血压正常男性的生活质量:LOMIR-MCT-IL研究。
J Hum Hypertens. 1996 Feb;10(2):117-22.
5
Once-daily treatment of essential hypertension with captopril.
J Clin Hypertens. 1986 Dec;2(4):379-87.
6
Prazosin in hypertension with and without methyldopa.哌唑嗪用于伴或不伴甲基多巴的高血压治疗
Clin Pharmacol Ther. 1979 Feb;25(2):143-8. doi: 10.1002/cpt1979252143.
7
[An open comparative study of captopril + hydrochlorothiazide versus chlorthalidone for the treatment of mild and moderate primary hypertension].卡托普利+氢氯噻嗪与氯噻酮治疗轻中度原发性高血压的开放对比研究
Arq Bras Cardiol. 1992 Nov;59(5):423-7.
8
[Treatment of severe resistant arterial hypertension with captopril. 58 patients, including 38 treated for more than 6 months (author's transl)].卡托普利治疗重度顽固性动脉高血压。58例患者,其中38例治疗超过6个月(作者译)
Nouv Presse Med. 1981 Apr 30;10(19):1571-4.
9
The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.降压联合治疗对脂质和葡萄糖代谢的影响:氢氯噻嗪加索他洛尔与氢氯噻嗪加卡托普利的对比
Int J Clin Pharmacol Ther. 1997 Jun;35(6):231-4.
10
[The effects of captopril and metoprolol on blood pressure and side effects in patients with mild to moderate hypertension].卡托普利和美托洛尔对轻至中度高血压患者血压及副作用的影响
Ugeskr Laeger. 1989 Apr 3;151(14):890-2.